Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
106451-92-7
1205744-09-7
1217717-09-3
1006592-62-6
181272-15-1
1334172-74-5
1339141-04-6 | 3-[(2-Bromophenyl)methyl]-5-(chloromethyl)-1,2,4-oxadiazole | AA00HT0J | MFCD19688997
1346809-48-0 | 2-(Methylamino)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinonitrile | AA00HTOY | MFCD16995277
1352393-84-0 | 7-Bromo-pyrazolo[1,5-a]pyridine-3-carboxylic acid | AA00HTW4 | MFCD20923164
1357387-24-6 | 2,2-Dimethyl-n-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)pyridin-2-yl]propanamide | AA00HUAX | MFCD18206639
1367707-20-7 | 5-Bromo-2-(2-methoxyethoxy)phenol | AA00HUM1 | MFCD22208528
1375477-15-8 | 2-Hydrazino-5-methyl-pyridine HCl | AA00HUZH | MFCD20261484
1391732-86-7 | (1-Fluorocyclohexyl)methanamine HCl | AA00HVCH | MFCD23378514
1401685-43-5 | 2-Ethynyl-3-fluoropyridine | AA00HVOT | MFCD22191371
1416551-60-4 | 8-Chloro-7-iodo-2-methylimidazo[1,2-a]pyridine | AA00HW2O | MFCD25542236
1423033-81-1 | 4-Bromo-2-methanesulfonyl-1-nitrobenzene | AA00HWDU | MFCD22565863